Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.

Adeyinka Charles Adejumo 1, 2 Samson Alliu 3 Tokunbo Opeyemi Ajayi 4 Kelechi Lauretta Adejumo 5 Oluwole Muyiwa Adegbala 6 Nnaemeka Egbuna Onyeakusi 7 Akintunde Micheal Akinjero 6 Modupeoluwa Durojaiye 8 Terence Ndonyi Bukong 2, 9, *
* Auteur correspondant
1 UMass Lowell - University of Massachusetts at Lowell
2 UMASS - University of Massachusetts Medical School [Worcester]
3 Department of Medicine
4 Howard County General Hospital
5 Public Health Program
6 Department of medicine
7 Bronx-Lebanon Hospital Center
8 UAB - The University of Alabama at Birmingham [ Birmingham]
9 INRS-IAF - Institut Armand Frappier
Abstract : Cannabis use is associated with reduced prevalence of obesity and diabetes mellitus (DM) in humans and mouse disease models. Obesity and DM are a well-established independent risk factor for non-alcoholic fatty liver disease (NAFLD), the most prevalent liver disease globally. The effects of cannabis use on NAFLD prevalence in humans remains ill-defined. Our objective is to determine the relationship between cannabis use and the prevalence of NAFLD in humans. We conducted a population-based case-control study of 5,950,391 patients using the 2014 Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Survey (NIS) discharge records of patients 18 years and older. After identifying patients with NAFLD (1% of all patients), we next identified three exposure groups: non-cannabis users (98.04%), non-dependent cannabis users (1.74%), and dependent cannabis users (0.22%). We adjusted for potential demographics and patient related confounders and used multivariate logistic regression (SAS 9.4) to determine the odds of developing NAFLD with respects to cannabis use. Our findings revealed that cannabis users (dependent and non-dependent) showed significantly lower NAFLD prevalence compared to non-users (AOR: 0.82[0.76-0.88]; p<0.0001). The prevalence of NAFLD was 15% lower in non-dependent users (AOR: 0.85[0.79-0.92]; p<0.0001) and 52% lower in dependent users (AOR: 0.49[0.36-0.65]; p<0.0001). Among cannabis users, dependent patients had 43% significantly lower prevalence of NAFLD compared to non-dependent patients (AOR: 0.57[0.42-0.77]; p<0.0001). Our observations suggest that cannabis use is associated with lower prevalence of NAFLD in patients. These novel findings suggest additional molecular mechanistic studies to explore the potential role of cannabis use in NAFLD development.
Type de document :
Article dans une revue
PLoS ONE, Public Library of Science, 2017, 12 (4), pp.e0176416. 〈10.1371/journal.pone.0176416〉
Liste complète des métadonnées

Littérature citée [52 références]  Voir  Masquer  Télécharger
https://hal-riip.archives-ouvertes.fr/pasteur-01538556
Contributeur : Michel Courcelles <>
Soumis le : mardi 13 juin 2017 - 16:41:13
Dernière modification le : lundi 5 février 2018 - 15:22:10
Document(s) archivé(s) le : mardi 12 décembre 2017 - 14:26:47

Fichier

journal.pone.0176416.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

RIIP | INRS-IAF

Citation

Adeyinka Charles Adejumo, Samson Alliu, Tokunbo Opeyemi Ajayi, Kelechi Lauretta Adejumo, Oluwole Muyiwa Adegbala, et al.. Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.. PLoS ONE, Public Library of Science, 2017, 12 (4), pp.e0176416. 〈10.1371/journal.pone.0176416〉. 〈pasteur-01538556〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

51

Téléchargements de fichiers

13

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD